Recent Finacing
Recent Raise
Magenta Therapeutics develops stem-cell-based therapies and transplant technologies—targeted conditioning, stem cell mobilization and expansion—and is advancing MGTA-456 cell therapy (Phase 2) for inherited metabolic and hematologic diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
